Categories: Appointment

Dr. R.K Patel and Dr. Ambrish Mithal appointed as domain experts on the Governing Board of the National Health Authority

Kolkata, April 30, 2019: The Government appointed Dr. R.K Patel and Dr. Ambrish Mithal as domain experts on the Governing Board of National Health Authority (NHA). 

Dr. R K Patel is Honorary Director of the UN Mehta Institute of Cardiology & Research Centre, Ahmedabad and is currently holding the charge of Member Secretary of UN Mehta Institute of Cardiology & Research Centre since 2002. He has been a Ph.D. guide in the subject of General Medicine and Cardiologist at Gujarat University and Cardiologist to Hon’ble Governor to Gujarat since 1995. In addition, he is a member of the Working Group on Medical Education to assist ‘The National Knowledge Commission’, Government of India for revolutionizing education in India to bring it at par with international standards in 2007. 

Dr. Ambrish Mithal, MD, DM, is heading the Endocrinology and Diabetes division at Medanta Hospital, Medicity, Gurugram, and has been awarded Padma Bhushan in 2015 and Dr. B C Roy Award in 2017. Besides, in 2013, he won the Springer Citation Award for his paper on ‘Global Vitamin D status’ – Osteoporosis International and in 2016 he was awarded the International Osteoporosis Foundation (IOF) President’s Award for Outstanding Contribution to the IOF. 

The Union Cabinet on 2nd January 2019 had upgraded the National Health Agency into a new National Health Authority (NHA) to improve the implementation of the Pradhan Mantri Jan Arogya Yojana (PM-JAY) and to better regulate the constituents of the health insurance/assurance ecosystem.

The NHA is governed by a Governing Board comprising the Chair and 11 members. The Governing Board is the supreme decision-making authority of NHA is responsible for all policy related matters to PM-JAY and the Authority. 

As part of its constitution, two domain experts from the fields of administration, insurance, public and private health, healthcare providers, economics, public health, and management are to be included in the Board. Other members are CEO NITI Aayog, Member Secretary (Expenditure), Ministry of Finance, Member Secretary (Health and Family Welfare), CEO National Health Authority and five Principal Secretaries (Health) of the state governments on a rotational basis.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

10 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago